DACT1 and hepatocellular carcinoma: For example, recent study in HCC demonstrates that the decreased DACT1 expression leads to accumulation of both cytoplasmic and nuclear β-catenin, which results in activation of Wnt/β-catenin signaling and promotes HCC progression [18].